Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sensitivity and Specificity × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 6 Lymphoid 4 Thoracic 1 Plasma cell 1 Gastrointestinal 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 731 Bortezomib 407 Lenalidomide 393 Cyclophosphamide 314 Melphalan 242 Calcium Dobesilate 218 daratumumab 203 pomalidomide 172 carfilzomib 151 fludarabine 114 Thalidomide 107 fludarabine phosphate 105 Filgrastim 100 Peripheral Blood Stem Cell Transplantation 99 ixazomib 81 dexamethasone acetate 75 Whole-Body Irradiation 74 Granulocyte Colony-Stimulating Factor 74 Mycophenolic Acid 70 Busulfan 70 dexamethasone 21-phosphate 62 Tacrolimus 61 Prednisone 58 auricularum 57 isatuximab 54 belantamab mafodotin 54 Cyclosporine 54 elotuzumab 53 Antilymphocyte Serum 47 Etoposide 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01886976 2016-01-28

CART-138

Chinese PLA General Hospital

Phase 1/2 Unknown

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡